4//SEC Filing
Myer Vickesh 4
Accession 0001179110-19-001682
CIK 0001650664other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 7:35 PM ET
Size
7.7 KB
Accession
0001179110-19-001682
Insider Transaction Report
Form 4
Myer Vickesh
Chief Technology Officer
Transactions
- Award
Stock Option (right to buy)
2019-02-06+48,750→ 48,750 totalExercise: $21.10Exp: 2029-02-05→ Common Stock (48,750 underlying) - Award
Restricted Stock Units
2019-02-06+8,125→ 8,125 total→ Common Stock (8,125 underlying)
Footnotes (3)
- [F1]This option was granted on February 6, 2019 and is scheduled to vest over four years in equal monthly installments beginning on February 6, 2019 through February 6, 2023.
- [F2]Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc.
- [F3]The restricted stock unit award is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023. Shares will be delivered to the Reporting Person when units vest.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001742806
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 7:35 PM ET
- Size
- 7.7 KB